Literature DB >> 51828

Inhibition of T- and B-lymphocyte functions by normal immunosuppressive protein.

N Hanna, R Kalderon, D Nelken.   

Abstract

Normal immunosuppressive protein (NIP) isolated from human plasma was studied in two well defined systems. (1) Spontaneous rosettes of sheep red blood cells with human peripheral blood lymphocytes and PHA-induced lymphocyte cytotoxicity as indicators for T-cell function. (2) Rosette formation tests of human lymphocytes with antibody-coated erythrocytes or erythrocytes coated with antibody and complement as well as antibody-induced lymphocyte-mediated cytotoxicity represented non-T-cell activity. While NIP did not inhibit the formation of any of the above mentioned rosettes, it practically prevented both PHA-induced and antibody-mediated lymphocyte cytotoxicity. Relatively small amounts of NIP inhibited PHA-induced cytotoxicity while higher doses were required for the inhibition of antibody-mediated lymphocyte cytotoxicity. Possible mechanisms of its suppressive activity are discussed. NIP was found to be heat-stable and did not show any species specificity, as NIP preparations from human plasma were immunosuppressive in human, mouse and guinea-pig systems.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51828      PMCID: PMC1445971     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Effect of large doses of an alpha2-glycoprotein fraction on the survival of rat skin homografts.

Authors:  J F MOWBRAY
Journal:  Transplantation       Date:  1963-01       Impact factor: 4.939

2.  Successful skin bomografts in mature non-littermate rats treated with fractions containing alpha-globulins.

Authors:  B B KAMRIN
Journal:  Proc Soc Exp Biol Med       Date:  1959-01

3.  Immunoregulatory d-globulin: failure to inhibit antibody response when administered after antigen exposure.

Authors:  A H Glasgow; J O Menzoian; S R Cooperband; R B Nimberg; K Schmid; J A Mannick
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

4.  In vitro inhibition of plaque and rosette formation by globulin.

Authors:  M Glaser; I Cohen; D Nelken
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

5.  Synergistic effect of -globulin and other immunosuppressive agents on rat skin allograft survival.

Authors:  D Nelken; M Glaser
Journal:  Transplantation       Date:  1972-08       Impact factor: 4.939

6.  Inhibitory effect of alpha-globulin on the second set allograft reaction.

Authors:  M Glaser; D Nelken
Journal:  Proc Soc Exp Biol Med       Date:  1972-07

7.  The effect of immunoregulatory alpha globulin (IRA) on antigen-mediated macrophage immobilization in vitro.

Authors:  R C Davis; S R Cooperband; J A Mannick
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

8.  Competitive blockade of lymphocyte stimulation by a serum immuno-regulatory alpha globulin (IRA).

Authors:  S R Cooperband; R C Davis; K Schmid; J A Mannick
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

9.  Bone marrow origin of complement-receptor lymphocytes.

Authors:  P Dukor; C Bianco; V Nussenzweig
Journal:  Eur J Immunol       Date:  1971-12       Impact factor: 5.532

10.  The human rosette-forming cell as a marker of a population of thymus-derived cells.

Authors:  J Wybran; M C Carr; H H Fudenberg
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

View more
  7 in total

1.  Inhibition by human serum of lymphocyte proliferation stimulated by purified protein derivative of tuberculin and bacillus Calmette-Guérin.

Authors:  R Herman-Brand; B M Sultzer
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

2.  The inhibitory effect of normal immunosuppressive protein on lymphocytes mediating natural killing activity.

Authors:  R Goren; D Nelken
Journal:  Immunology       Date:  1981-03       Impact factor: 7.397

3.  Normal immunosuppressive protein: inhibitory effect on hemagglutinin and plaque formation as well as B cell transformation by Epstein-Barr virus.

Authors:  D Nelken; H Ovadia
Journal:  Experientia       Date:  1982-08-15

4.  Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells.

Authors:  N Hanna; H Ovadia; D Nelken
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

5.  Normal immunosuppressive protein. Isolation of a glycoprotein active fraction.

Authors:  R Goren; D Nelken
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

6.  Studies with a human plasma-derived immunosuppressive, anti-lymphoma factor.

Authors:  J L Farmer; M D Prager
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients.

Authors:  M B Constantian
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.